These findings uncover an important role for TET2 mutations in regulating NET clearance that may contribute to the higher risk of individuals with CH for developing NET-mediated pathologies such as atherosclerosis or COPD. The gene discussed is TET2; the disease is chronic obstructive pulmonary disease.